263 related articles for article (PubMed ID: 8257633)
1. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
Arya SK
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
[TBL] [Abstract][Full Text] [Related]
2. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
[TBL] [Abstract][Full Text] [Related]
3. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.
Rappaport J; Lee SJ; Khalili K; Wong-Staal F
New Biol; 1989 Oct; 1(1):101-10. PubMed ID: 2562188
[TBL] [Abstract][Full Text] [Related]
4. Function of exon 2 in optimal trans-activation by Tat of HIV type 2.
Pagtakhan AS; Tong-Starksen SE
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1367-72. PubMed ID: 8573394
[TBL] [Abstract][Full Text] [Related]
5. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
[TBL] [Abstract][Full Text] [Related]
6. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
[TBL] [Abstract][Full Text] [Related]
7. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
8. The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of a TAR2-containing LTR.
Chang YN; Jeang KT
Nucleic Acids Res; 1992 Oct; 20(20):5465-72. PubMed ID: 1437564
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1.
Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA
Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886
[TBL] [Abstract][Full Text] [Related]
10. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
Derse D; Newbold SH
Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
[TBL] [Abstract][Full Text] [Related]
12. Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.
Elangovan B; Subramanian T; Chinnadurai G
J Virol; 1992 Apr; 66(4):2031-6. PubMed ID: 1548750
[TBL] [Abstract][Full Text] [Related]
13. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
Lisziewicz J; Rappaport J; Dhar R
New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
[TBL] [Abstract][Full Text] [Related]
14. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
[TBL] [Abstract][Full Text] [Related]
15. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
Sadaie MR; Mukhopadhyaya R; Benaissa ZN; Pavlakis GN; Wong-Staal F
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1257-63. PubMed ID: 2078407
[TBL] [Abstract][Full Text] [Related]
16. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
17. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
Delling U; Roy S; Sumner-Smith M; Barnett R; Reid L; Rosen CA; Sonenberg N
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6234-8. PubMed ID: 2068104
[TBL] [Abstract][Full Text] [Related]
18. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP
Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
[TBL] [Abstract][Full Text] [Related]
19. Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?
Tiley LS; Brown PH; Cullen BR
Virology; 1990 Oct; 178(2):560-7. PubMed ID: 2219707
[TBL] [Abstract][Full Text] [Related]
20. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
Verhoef K; Koper M; Berkhout B
Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
